Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-06-30
1994-10-18
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 50, 514934, 536 41, A61K 3170, C07G 300
Patent
active
053568826
ABSTRACT:
Pyrimidine 4'-thionucleosides of the formula I ##STR1## wherein Y is hydroxy or amino, and X is chloro, bromo, iodo, trifluoromethyl, C.sub.2-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 haloalkenyl or C.sub.2-6 alkynyl and physiologically functional derivatives thereof. These compounds have utility as anti-vital agents.
REFERENCES:
patent: 4211773 (1980-07-01), Lopez et al.
patent: 5055457 (1991-10-01), Schrinner et al.
patent: 5159067 (1992-10-01), Schinazi et al.
patent: 5215970 (1993-06-01), Datema et al.
European Patent Office Action mailed on Jan. 28, 1994.
Huang et al: Nucleosides & Nucleotides, 1993, "A Facile Synthesis of 4'-thio-2'-deoxypyrimidine Nucleosides and Preliminary Studies on Their Properties," pp. 139-147.
Reist et al., J. Org. Chem., vol. 33, pp. 189-192. Thio Sugars. "Synthesis of the Adenine Nucleosides of 4-thio-D-xylose and 4-thio-D-arabinose," (1968).
Reist et al, [No Journal Title Available], vol. 86, pp. 5658-5663, "Synthesis of 4-thio-D- and -L-ribofuranose and the corresponding adenine nucleosides," (1964).
Bellon et al, Biochem. Biophys. Res. Comm., vol. 184, 797-803, "Sugar Modified Oligonucleotide: Synthesis, nuclease resistance and base pairing of oligodeoxynucleoties containing 1-(4'-thio-.beta.-D-ribofuranosy)-thymine," (1992).
Bellon et al, Nucleosides & Nucleotides, vol. 11, pp. 1467-1479, "Efficient Synthesis of 4-thio-D-ribofuranose and some 4'-thioribonucleosides," (1992).
Clement & Berger, Med. Chem. Res., vol. 2, pp. 154-164, "Biological and antitumor activity of a series of 4'thio'-.beta.-D-ribofuranosy pyrimidines," (1992).
Dyson et al., Carbohydrate Research, vol. 216, pp. 237-248, "An improved synthesis of benzyl 3,5-di-O-benzyl-2-deoxy-1,3-dithio-D-erythro-pentofuranoside, an intermediate in the synthesis of 4'-thionucleosides," (1991).
Nayal & Whistler, Liebigs Ann. Chem., vol. 741, pp. 131-138, "Anomere methyl-2-desoxy-4-thio-D-erythro-pentofuranodise," (1970).
J. Med. Chem. 1991, 34, pp. 2361-2366, "Synthesis and Biological Activity of 2'-Deoxy-4'-thio Pyrimidine Nucleosides.sup.1 " Secrest III et al.
J. Med. Chem. 1991, 34, pp. 2782-2786, "The Synthesis and Antiviral Activity of Some 4'-Thio-2'deoxy Nucleoside Analogues" Dyson et al.
J. Chem. Soc. Chem. Commun., 1991, pp. 741-742, "The Synthesis and Antiviral Properties of E-5-(2-Bromovinyl)-4'-thio-2'-deoxyuridine" Dyson et al.
J. Chem. Soc. Chem. Commun., 1991, pp. 1421-1422, "Stereocontrolled Preparation of Cyclic Xanthate; a Novel Synthetic Route etc." Uenishi et al.
J. Med. Chem., 1992, 35, pp. 533-538, "Synthesis and Anti-HIV Activity of 4'-Thio-2',3'-dideoxynucleosides" Secrist III et al.
Fu et al.; Nucleic Acid Chemistry, vol. 1, 1978; pp. 317-323.
Fu et al.; J. Org. Chem., vol. 41, (24); 1976; pp. 3831-3834.
Whistler et al.; J. Org. Chem., vol. 36, No. 1; 1971; pp. 108-110.
Ototani et al.; J. Med. Chem., vol. 17, No. 5; 1974; pp. 535-537.
Bovek et al.; J. Med. Chem., vol. 18, No. 8; 1975; pp. 784-787.
Benz et al.; Liebigs Annalen der Chemie No. 8; 1984; pp. 1408-1423.
Kim et al.; Chem. Abstracts, vol. 84; 1986; 150879s; p. 575.
Pickering et al.; Chem. Abstracts, vol. 85; 1978; 191t; p. 12.
Kim et al.; Chem. Abstracts, vol. 83; 1975; 59198n; p. 543.
Miles et al.; Chem. Abstracts, vol. 73; 1970; 45760w.
Miles et al.; Chem. Abstracts, vol. 70; 1969; 72465y; p. 340.
Nishi et al.; Chem. Abstracts, vol. 106; 1987; 18966m; p. 648.
Anisuzzsman et al.; Chem. Abstracts, vol. 93; 1980; 47077r; p. 978.
Ritchie et al.; Chem. Abstracts, vol. 89; 6493x; p. 560.
Stoeckler et al.; Chem. Abstracts, vol. 92; 1980; 54127q; p. 276.
Ritchie et al.; Chem Abstracts, vol. 80; 1974; 3744h; p. 3749.
Anisuzzsman et al; Chem. Abstracts, vol. 79; 1973; 63102m; p. 174.
Bobek et al.; Chem. Abstracts, vol. 76; 1972; 122281g; p. 103.
Keyser et al.; Chem. Abstracts, vol. 92; 1980; 163934w; p. 600.
Bobek et al.; Chem. Abstracts, vol. 73; 1970; 4139g; pp. 356-357.
Reist et al.; Chem. Abstracts, vol. 68; 1968; 40003p; p. 3903.
Verhoaven et al.; Chem. Abstracts, vol. 110; 1989; 18139b; p. 20.
Miura et al.; Chem. Abstracts, vol. 106; 1987; 95695z; p. 30.
Smith et al.; Chem. Abstracts, vol. 86; 1977; 182968c; p. 19.
Adamson et al.; Chem. Abstracts, vol. 86; 1977; 133421k; p. 25.
Follmann et al.; Chem. Abstracts, vol. 83; 1975; 189442y; p. 138.
Wilson et al.; Chem. Abstracts, vol. 83; 1975; 97802n; p. 641.
Lau et al.; Chem. Abstracts, vol. 79; 1973; 13415v; p. 9.
Wilson et al.; Chem. Abstracts, vol. 75; 1971; 94595w; p. 11.
Hoffman et al.; Chem. Abstracts, vol. 73; 1970; 77542t; p. 400.
Chem. Abs. No. RN 6741-74-8.
Chem. Abs. No. RN 6741-72-6.
Chem. Abs. No. RN 6741-71-5.
Chem. Abs. No. RN 2500-79-0.
Coe Paul L.
Walker Richard
Rollins John W.
University of Birmingham
LandOfFree
Antiviral pyrimidine nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral pyrimidine nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral pyrimidine nucleosides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2372508